Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study.
Nelli F, Fabbri A, Virtuoso A, Giannarelli D, Marrucci E, Fiore C, Giron Berrios JR, Schirripa M, Signorelli C, Chilelli MG, Primi F, Panichi V, Caterini L, Farinelli S, Silvestri MA, Ruggeri EM.
Nelli F, et al. Among authors: panichi v.
Clin Exp Med. 2024 Jan 20;24(1):13. doi: 10.1007/s10238-023-01263-2.
Clin Exp Med. 2024.
PMID: 38244147
Free PMC article.